SyntekaBio, Inc. (KOSDAQ: 226330)
South Korea
· Delayed Price · Currency is KRW
5,690.00
+10.00 (0.18%)
Nov 18, 2024, 2:29 PM KST
SyntekaBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 15, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 86,668 | 216,882 | 115,982 | 241,650 | 307,326 |
| Market Cap Growth | -39.09% | 87.00% | -52.00% | -21.37% | - |
| Enterprise Value | 73,945 | 189,591 | 86,513 | 201,583 | - |
| Last Close Price | 5680.00 | 14240.00 | 8580.00 | 17900.00 | 23000.00 |
| PS Ratio | 831.73 | 1757.47 | 475.35 | 763.13 | 504.08 |
| PB Ratio | 2.74 | 6.95 | 3.69 | 8.75 | 7.40 |
| P/TBV Ratio | 3.32 | 7.05 | 3.76 | 8.89 | 7.48 |
| EV/Sales Ratio | 738.24 | 1536.32 | 354.57 | 636.59 | - |
| Debt / Equity Ratio | 0.22 | 0.07 | 0.35 | 0.32 | 0.02 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | - |
| Quick Ratio | 1.04 | 1.02 | 1.59 | 28.00 | 39.87 |
| Current Ratio | 1.10 | 1.13 | 1.68 | 30.82 | 40.04 |
| Return on Equity (ROE) | -22.07% | -36.36% | -15.25% | -42.80% | - |
| Return on Assets (ROA) | -14.59% | -14.13% | -11.93% | -9.87% | - |
| Return on Capital (ROIC) | -19.38% | -20.22% | -18.65% | -14.06% | - |
| Earnings Yield | -15.84% | -5.26% | -3.89% | -6.13% | -2.11% |
| FCF Yield | -26.12% | -8.04% | -14.57% | -5.59% | -1.78% |
| Buyback Yield / Dilution | -10.75% | -5.94% | -0.37% | -1.65% | - |
| Total Shareholder Return | -10.75% | -5.94% | -0.37% | -1.65% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.